Prostate palpation device for prostate cancer screening bancodepatentes - Banco de Patentes

Currently, prostate cancer is screened with prostate specific antigen (PSA) blood testing and digital rectal examination, which detects cancer in 18% of patients with normal PSA. This physical examination has a disadvantage of subjectivity, as it depends on the experience of the examiner and the apprehension of the patient.

PROSTACTO is a device for prostate palpation as a screening method for prostate cancer, composed of a palpation system that transforms the collected information into objective, reproducible and useful, allowing the generation of an objective map of stiffness, reaching the entire peripheral area, in a short space of time and performed less aggressively than touch.